These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10133135)

  • 21. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality assurance in blood transfusion: the advantages and limitations].
    Hergon E
    Transfus Clin Biol; 1998 Apr; 5 Suppl 1():36S-41S. PubMed ID: 9622844
    [No Abstract]   [Full Text] [Related]  

  • 23. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

  • 24. The value of Good Manufacturing Practice to a Blood Service in managing the delivery of quality.
    Slopecki A; Smith K; Moore S
    Vox Sang; 2007 Apr; 92(3):187-96. PubMed ID: 17348867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What is the use of hemovigilance?].
    Quaranta JF; Canivet N
    Transfus Clin Biol; 1998 Dec; 5(6):415-21. PubMed ID: 9894333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Snyder v. American Association of Blood Banks: a re-examination of liability for medical practice guideline promulgators.
    Noble A; Brennan TA; Hyams AL
    J Eval Clin Pract; 1998 Feb; 4(1):49-62. PubMed ID: 9524912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-examining blood use to improve quality care.
    Simmons JC
    Qual Lett Healthc Lead; 2001 Sep; 13(9):2-12, 1. PubMed ID: 11570060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Product liability. Fault lines.
    Wilder G
    Health Serv J; 2001 Jun; 111(5760):suppl 12. PubMed ID: 11436764
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood money: blood donors' attitudes to changes in the New Zealand blood transfusion service.
    Howden-Chapman P; Carter J; Woods N
    BMJ; 1996 May; 312(7039):1131-2. PubMed ID: 8620129
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of improved safety on maintaining a sufficient blood supply.
    Reynolds E; Wickenden C; Oliver A
    Transfus Clin Biol; 2001 Jun; 8(3):235-9. PubMed ID: 11499967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes.
    Berte LM; Dechristopher PJ
    MLO Med Lab Obs; 1996 Mar; 28(3):28-34. PubMed ID: 10156309
    [No Abstract]   [Full Text] [Related]  

  • 32. Current and emerging infectious risks of blood transfusions.
    Busch MP; Kleinman SH; Nemo GJ
    JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733
    [No Abstract]   [Full Text] [Related]  

  • 33. Toward universal pathogen reduction of the blood supply (Conference Report, p. 3002).
    Marks P; Verdun N
    Transfusion; 2019 Sep; 59(9):3026-3028. PubMed ID: 31218709
    [No Abstract]   [Full Text] [Related]  

  • 34. Worldwide overview of existing haemovigilance systems.
    Faber JC
    Transfus Apher Sci; 2004 Oct; 31(2):99-110. PubMed ID: 15501414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sensibility of safety: reflections on the Krever inquiry's final report.
    Hoey J
    CMAJ; 1998 Jan; 158(1):59-60. PubMed ID: 9475910
    [No Abstract]   [Full Text] [Related]  

  • 36. International views on universal leucodepletion: the perspective in NBS, Ireland.
    Murphy W
    Transfus Sci; 1998 Dec; 19(4):349-50. PubMed ID: 10351151
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quality control of homologous blood collection activities: 5 years' experience].
    Folléa G; Vives C; Bigey F; Kientz D; Waller C; Cazenave JP
    Transfus Clin Biol; 1998 Apr; 5(2):123-38. PubMed ID: 9618838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance of introduction of PCR in blood banks].
    Gürtler L
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):4-6. PubMed ID: 8653016
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blood monitoring at the dawn of the 21st century].
    Delbosc A; Weiller J; Dussert P
    Presse Med; 2000 May 27-Jun 3; 29(19):1066-71. PubMed ID: 10874919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemovigilance--a new name or an old, unfulfilled need].
    Heier HE
    Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2185. PubMed ID: 11006745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.